nisoldipine has been researched along with Pregnancy in 5 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The calcium antagonist nisoldipine (Bayer-Miles) was given orally (20 mg, 8-hourly) in the management of 12 selected cases of severe postpartum pregnancy-induced hypertension (PIH)." | 9.07 | Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results. ( Belfort, MA; Kirshon, B, 1992) |
| "The calcium antagonist nisoldipine (Bayer-Miles) was given orally (20 mg, 8-hourly) in the management of 12 selected cases of severe postpartum pregnancy-induced hypertension (PIH)." | 5.07 | Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results. ( Belfort, MA; Kirshon, B, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altura, BM | 1 |
| Altura, BT | 1 |
| Liu, W | 1 |
| Yasui, K | 1 |
| Opthof, T | 1 |
| Ishiki, R | 1 |
| Lee, JK | 1 |
| Kamiya, K | 1 |
| Yokota, M | 1 |
| Kodama, I | 1 |
| Belfort, MA | 1 |
| Kirshon, B | 1 |
| Li, FF | 1 |
| Fu, SX | 1 |
| Li, YS | 1 |
| Ahr, HJ | 1 |
| Krause, HP | 1 |
| Suwelack, D | 1 |
| Weber, H | 1 |
1 review available for nisoldipine and Pregnancy
| Article | Year |
|---|---|
Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Topics: Anesthesia; Animals; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Cell Membrane Pe | 1984 |
1 trial available for nisoldipine and Pregnancy
| Article | Year |
|---|---|
Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results.
Topics: Blood Pressure; Female; Heart Rate; Humans; Hypertension; Nisoldipine; Pilot Projects; Pregnancy; Pu | 1992 |
3 other studies available for nisoldipine and Pregnancy
| Article | Year |
|---|---|
Developmental changes of Ca(2+) handling in mouse ventricular cells from early embryo to adulthood.
Topics: Aging; Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Calcium-Binding Proteins; | 2002 |
[Effects of m-nisoldipine and nisoldipine on isolated uterine muscle].
Topics: Acetylcholine; Adult; Animals; Endometrium; Female; Humans; In Vitro Techniques; Isomerism; Middle A | 1992 |
Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
Topics: Administration, Oral; Animals; Autoradiography; Calcium Channel Blockers; Dogs; Female; Injections, | 1988 |